Filing Flows › Enovix (ENVX) › Q2 2026 › vs Q2 2025
Enovix (ENVX) Q2 2026 vs Q2 2025 (year over year)
Enovix's revenue rose $1.6M (+21%) from $7.5M in Q2 2025 to $9.0M in Q2 2026.
Enovix, Q2 2026: revenue $9.0M (+21% year over year), operating margin -479.8%, net loss $43.1M, operating cash flow −$21.8M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $9.0M | $7.5M | $1.6M | +21% |
| Income tax benefit | $441K | $861K | −$420K | -49% |
| Net loss | $43.1M | $44.3M | −$1.2M | -3% |
| Costs & expenses | $52.5M | $52.6M | −$53K | -0.1% |
| Operating costs | $52.3M | $51.2M | $1.1M | +2% |
| Interest & other, net | $222K | $1.4M | −$1.2M | -84% |
| Cost of revenue | $7.7M | $5.5M | $2.2M | +40% |
| Research & development | $24.4M | $28.1M | −$3.7M | -13% |
| SG&A | $20.2M | $17.5M | $2.6M | +15% |
| Operating cash sources | $44.9M | $48.8M | −$4.0M | -8% |
| Depreciation & amortization | $10.0M | $8.8M | $1.2M | +14% |
| Share-based compensation | $13.0M | $14.1M | −$1.1M | -8% |
| Cash used in operations | $21.8M | $25.9M | −$4.1M | -16% |
| Net loss absorbed | $43.1M | $44.3M | −$1.2M | -3% |
| Working capital & other | $1.8M | $4.5M | −$2.8M | -61% |
Questions
How much did Enovix's revenue grow year over year in Q2 2026?
Enovix's revenue rose $1.6M (+21%) from $7.5M in Q2 2025 to $9.0M in Q2 2026.